EXTRAMAMÁRNÍ PAGETOVA CHOROBA: ZPRÁVA O REKONSTRUKCI VULVY MYOKUTÁNNÍM LALOKEM M. GRACILIS PO ÚPLNÉ VULVEKTOMII

Stáhnout PDF

Autoři: T. S. Simão
Působiště autorů: São Paulo, Brazil ; Plastic Surgery and Burns Department, São Paulo Hospital for State Civil Servants (HSPE-SP), São Paulo, Brazil ¹; Plastic Surgeon in private practice ²
Vyšlo v časopise: ACTA CHIRURGIAE PLASTICAE, 62, 3-4, 2020, pp. 111-114

Zdroje

1. Hendi A., Perdikis G., Snow JL. Unifocality of extramammary Paget disease. J Am Acad Dermatol. 2008, 59 : 811–13.

2. Shiomi T., Yoshida Y., Shomori K., Yamamoto O., Ito H. Extramammary Paget’s disease: Evaluation of the histopathological patterns of Paget cell proliferation in the epidermis. Journal of Dermatology. 2011, 38 : 1054–7.

3. Paget J. One disease of the mammary areola proceeding cancer of the mammary gland. St Barth Hosp Rep. 1874, 10 : 87–9.

4. Crocker HR. Paget’s disease affecting the scrotum und penis. Trans Pathol Soc Lond. 1889, 40 : 187–91.

5. Zeng A., Qiao Q., Zhao R., Song K., Long X. Anterolateral Thigh Flap–Based Reconstruction for Oncologic Vulvar Defects. Plast. Reconstr. Surg. 2011, 127 : 1939–45.

6. Salgarello M., Farallo E., Barone-Adesi L., Cervelli D., Scambia G., Salerno G., Margariti PA. Flap Algorithm in Vulvar Reconstruction after Radical, Extensive Vulvectomy. Ann Plast Surg. 2005, 54 : 184–90.

7. Aoyagi S., Akiyama M., Shimizu H. High expression of Ki-67 and cyclin D1 in invasive extramammary Paget’s disease. J Dermatol Sci. 2008, 50 : 177–84.

8. Wagner G., Sachse MM. Extramammary Paget disease –⁠ clinical appearance, pathogenesis, management. JDDG. 2011, 9 : 448–54.

9. Grelck KW., Nowak MA., Doval M. Signet Ring Cell Perianal Paget Disease: Loss of MUC2 Expression and Loss of Signet Ring Cell Morphology Associated With Invasive Disease. Am J Dermatopathol. 2011, 33 : 616–20.

10. Fanning J., Lambert HC., Hale TM., Morris PC., Schuerch C. Paget’s disease of the vulva: prevalence of associated vulvar adenocarcinoma, invasive Paget’s disease, and recurrence after surgical excision. Am J Obstet Gynecol. 1999, 180 : 24–7.

11. Smith KJ., Tuur S., Corvette D., Lupton GP., Skelton HG. Cytokeratin 7 staining in mammary and extramammary Paget’s disease. Mod Pathol. 1997, 10 : 1069–74.

12. Ellis PE., Fong LF., Rolfe KJ. et al. The role of p53 and Ki-67 in Paget’s disease of the vulva and the breast. Gynecol Oncol. 2002, 86 : 150–6.

13. Wu ML., Guitart J. Low speciﬁcity of cytokeratin 20 in the diagnosis of extramammary Paget’s disease. Br J Dermatol. 2000, 142 : 569–91.

14. Perrotto J., Abbott JJ., Ceilley RI., et al. The role of immunohistochemistry in discriminating primary from secondary extramammary Paget disease. Am J Dermatopathol. 2010, 32 : 137–43.

15. Chen S., Moroi Y., Urabe K., Takeuchi S. Concordant overexpression of p-FAK and p-ERK1/2 in extramammary Paget’s disease. Arch. Dermatol. Res. 2008, 300 : 195–201.

16. Mijiddorj T., Kajihara I., Tasaki Y., et al. Serum cell-free DNA levels are a useful marker for extramammary Paget disease. Br J Dermatol. 2019, 181 : 505–11.

17. Nakamura Y., Tanese K., Hirai I., et al. Serum cytokeratin 19 fragment 21-1 and carcinoembryonic antigen combination assay as a biomarker of tumour progression and treatment response in extramammary Paget disease. Br J Dermatol. 2019, 181 : 535–43.

18. Armes JE., Lourie R., Bowlay G., Tabrizi S. Pagetoid Squamous Cell Carcinoma In Situ of the Vulva: Comparison With Extramammary Paget Disease and Nonpagetoid Squamous Cell Neoplasia. Int J Gynecol Pathol. 2008, 27 : 118–24.

19. Hatta N., Yamada M., Hirano T., Fujimoto A, Morita R. Extramammary Paget’s disease: treatment, prognostic factors and outcome in 76 patients. Br J Dermatol. 2008, 158 : 313–18.